These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 34204445)
21. LncRNA-ATB: An indispensable cancer-related long noncoding RNA. Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871 [TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications. Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794 [TBL] [Abstract][Full Text] [Related]
23. Molecular Mechanisms of lncRNAs in the Dependent Regulation of Cancer and Their Potential Therapeutic Use. García-Padilla C; Dueñas Á; García-López V; Aránega A; Franco D; Garcia-Martínez V; López-Sánchez C Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054945 [TBL] [Abstract][Full Text] [Related]
24. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis. El Khodiry A; Afify M; El Tayebi HM World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445 [TBL] [Abstract][Full Text] [Related]
25. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells. Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982 [TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges. Yang Z; Guo X; Li G; Shi Y; Li L Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810 [TBL] [Abstract][Full Text] [Related]
27. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110 [TBL] [Abstract][Full Text] [Related]
28. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers. Xin Y; Li Z; Shen J; Chan MT; Wu WK Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049 [TBL] [Abstract][Full Text] [Related]
29. Gene expression profile of a newly established choriocarcinoma cell line, iC3-1, compared to existing choriocarcinoma cell lines and normal placenta. Kobayashi Y; Banno K; Shimizu T; Ueki A; Tsuji K; Masuda K; Kisu I; Nomura H; Tominaga E; Nagano O; Saya H; Aoki D Placenta; 2013 Feb; 34(2):110-8. PubMed ID: 23199791 [TBL] [Abstract][Full Text] [Related]
30. Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review. Zou Y; Zhong Y; Wu J; Xiao H; Zhang X; Liao X; Li J; Mao X; Liu Y; Zhang F Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226461 [TBL] [Abstract][Full Text] [Related]
31. Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics. Aranake-Chrisinger J; Huettner PC; Hagemann AR; Pfeifer JD Hum Pathol; 2016 Jun; 52():92-100. PubMed ID: 26980014 [TBL] [Abstract][Full Text] [Related]
32. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma. Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs: New biomarkers for prognosis and diagnosis of colon cancer. Deng H; Wang JM; Li M; Tang R; Tang K; Su Y; Hou Y; Zhang J Tumour Biol; 2017 Jun; 39(6):1010428317706332. PubMed ID: 28643604 [TBL] [Abstract][Full Text] [Related]
35. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star. Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of the Expression Profiles of Long Non-Coding RNAs with Associated ceRNA Network Involved in the Colon Cancer Staging and Progression. Wu M; Li W; Huang F; Sun J; Li KP; Shi J; Yang J; Li J; Li Y; Hu N; Hu Y Sci Rep; 2019 Nov; 9(1):16910. PubMed ID: 31729423 [TBL] [Abstract][Full Text] [Related]
37. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864 [TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA in prostate, bladder, and kidney cancer. Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479 [TBL] [Abstract][Full Text] [Related]
39. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175 [TBL] [Abstract][Full Text] [Related]
40. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets. Chandra Gupta S; Nandan Tripathi Y Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]